Last month, researchers at Ohio State University published a study in the Journal of Alternative Complimentary Medicine on the effect of EMPowerplus on people with Child-Onset Bipolar Spectrum Disorder. The results of the study are encouraging.
Researchers tracked the depression and mania levels of 7 child participants using the Kiddie Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present Episode-Depression Rating Scale and the Kiddie Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present Episode-Mania Rating Scale, respectively.
What the researchers discovered is that by the end of the 8-week, open pilot study, mean depression levels among participants had dropped 37% and mean mania levels had dropped almost in half.
This is encouraging news. While the sample is undoubtedly small, it reminds us of our roots in finding a way to address bipolar and it joins a growing body of evidence that shows the effectiveness of EMPowerplus in treating mood disorders.
We look forward to sharing more research news in the near future.